PlainRecalls
FDA Drug Moderate Class II Terminated

Calcipotriene BP (Monohydrate) for prescription compounding, packaged in a) 250mg (NDC 58597-8630-1); b) 500mg (NDC 58597-8630-2); c) 1g (NDC 58597-8630-3), Rx only, packed by American Pharmaceutical Ingredients, 6650 Highland Road, Waterford, MI 48327.

Reported: February 28, 2018 Initiated: February 9, 2018 #D-0477-2018

Product Description

Calcipotriene BP (Monohydrate) for prescription compounding, packaged in a) 250mg (NDC 58597-8630-1); b) 500mg (NDC 58597-8630-2); c) 1g (NDC 58597-8630-3), Rx only, packed by American Pharmaceutical Ingredients, 6650 Highland Road, Waterford, MI 48327.

Reason for Recall

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Details

Units Affected
10 g
Distribution
Nationwide within USA.
Location
Waterford, MI

Frequently Asked Questions

What product was recalled?
Calcipotriene BP (Monohydrate) for prescription compounding, packaged in a) 250mg (NDC 58597-8630-1); b) 500mg (NDC 58597-8630-2); c) 1g (NDC 58597-8630-3), Rx only, packed by American Pharmaceutical Ingredients, 6650 Highland Road, Waterford, MI 48327.. Recalled by American Pharmaceutical Ingredients LLC. Units affected: 10 g.
Why was this product recalled?
CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 28, 2018. Severity: Moderate. Recall number: D-0477-2018.